Literature DB >> 26177708

Exploring the diagnosis markers for gallbladder cancer based on clinical data.

Lingqiang Zhang1, Runchen Miao, Xiude Zhang, Wei Chen, Yanyan Zhou, Ruitao Wang, Ruiyao Zhang, Qing Pang, Xinsen Xu, Chang Liu.   

Abstract

Presently, no effective markers are available to facilitate gallbladder cancer (GBC) diagnosis. This study aims to explore available markers for GBC diagnosis. Clinical data of 144 GBC and 116 cholelithiasis patients were retrospectively reviewed. Logistic regression analysis was performed to evaluate GBC risk factors. A receiver operating characteristic (ROC) curve was used to assess the diagnosis value of the risk factors. By comparing the characteristic of GBC and cholelithiasis patients, the following factors exhibited statistical difference: age, gender, gallstones, total bilirubin (TB), alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), platelet count (PLT), CA125 (carcinoembryonic antigen 125), and CA199 (carbohydrate antigen 199). Logistic regression analysis indicated that age [odds ratio (OR), 1.032; 95%confidence interval (95% CI), 1.004 to 1.061; P = 0.024], gender (OR, 0.346; 95% CI, 0.167 to 0.716; P = 0.004), gallstones (OR, 0.027; 95% CI, 0.007 to 0.095; P < 0.001), ALP (OR, 1.003; 95% CI, 1.000 to 1.006; P = 0.032), TB (OR, 1.004; 95% CI, 1.000 to 1.009; P = 0.042), and CA125 (OR, 1.007; 95% CI, 1.002 to 1.013; P = 0.011) were independent risk factors for GBC. According to the ROC curve, CA125 [area under curve (AUC), 0.720], ALP (AUC, 0.713), TB (AUC, 0.636), and age (AUC, 0.573) were valuable diagnosis markers. Additionally, based on the independent risk factors, the GBC diagnosis model was established. Age, TB, ALP, and CA125 can be used as auxiliary diagnosis factors of GBC. The diagnosis model provides a quantitative tool for GBC diagnosis when comprehensively considering various risk factors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177708     DOI: 10.1007/s11684-015-0402-2

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  23 in total

1.  Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.

Authors:  Sue K Park; Gabriella Andreotti; Asif Rashid; Jinbo Chen; Philip S Rosenberg; Kai Yu; Jennifer Olsen; Yu-Tang Gao; Jie Deng; Lori C Sakoda; Mingdong Zhang; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

Review 2.  Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy.

Authors:  Carolina Bizama; Patricia García; Jaime A Espinoza; Helga Weber; Pamela Leal; Bruno Nervi; Juan Carlos Roa
Journal:  Cancer Treat Rev       Date:  2015-01-20       Impact factor: 12.111

3.  Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.

Authors:  Ujjawal Sharma; Deeksha Pal; Shrawan Kumar Singh; Nandita Kakkar; Rajendra Prasad
Journal:  Biochimie       Date:  2014-06-05       Impact factor: 4.079

4.  Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China.

Authors:  Xingyuan Jiao; Jianlin Ren; Hongyuan Chen; Jinping Ma; Shaoqi Rao; Ke Huang; Shengli Wu; Jian Fu; Xiaokang Su; Canqiao Luo; Jinsen Shi; Christoph E Broelsch
Journal:  Carcinogenesis       Date:  2010-11-26       Impact factor: 4.944

Review 5.  Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

Authors:  Yun-Feng Wang; Fei-Ling Feng; Xu-Hong Zhao; Zhen-Xiong Ye; He-Ping Zeng; Zhen Li; Xiao-Qing Jiang; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Gene       Date:  2013-08-27       Impact factor: 3.688

7.  Nuclear localization of alkaline phosphatase in cultured human cancer cells.

Authors:  Koji Yamamoto; Takumi Awogi; Keiji Okuyama; Nobuo Takahashi
Journal:  Med Electron Microsc       Date:  2003-03

8.  The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma.

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Jae Berm Park; Justin Sangwook Ko; Joon Hyeok Lee; Sung Joo Kim; Cheol-Keun Park
Journal:  World J Surg Oncol       Date:  2013-02-21       Impact factor: 2.754

9.  A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.

Authors:  Guo-Ying Wang; Yang Yang; Hua Li; Jian Zhang; Nan Jiang; Min-Ru Li; Huan-Bing Zhu; Qi Zhang; Gui-Hua Chen
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

10.  Risk factors of gallbladder cancer in Karachi-a case-control study.

Authors:  A Rehman Alvi; Nadeem Ahmed Siddiqui; Hasnain Zafar
Journal:  World J Surg Oncol       Date:  2011-12-09       Impact factor: 2.754

View more
  2 in total

Review 1.  The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective.

Authors:  Ismael Riquelme; Pablo Pérez-Moreno; Pablo Letelier; Priscilla Brebi; Juan Carlos Roa
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 2.  Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.

Authors:  Pablo Letelier; Ismael Riquelme; Alfonso H Hernández; Neftalí Guzmán; Jorge G Farías; Juan Carlos Roa
Journal:  Int J Mol Sci       Date:  2016-05-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.